753 related articles for article (PubMed ID: 26075331)
21. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
Kato T; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172827. PubMed ID: 31733218
[TBL] [Abstract][Full Text] [Related]
22. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto K
Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
[TBL] [Abstract][Full Text] [Related]
23. Investigational drugs for treating major depressive disorder.
Dhir A
Expert Opin Investig Drugs; 2017 Jan; 26(1):9-24. PubMed ID: 27960559
[TBL] [Abstract][Full Text] [Related]
24. [Ketamine for treatment of acute depression].
Hjerrild S; Bjerre J; Pedersen RH; Videbech P
Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.
Smith JW; Gastambide F; Gilmour G; Dix S; Foss J; Lloyd K; Malik N; Tricklebank M
Psychopharmacology (Berl); 2011 Sep; 217(2):255-69. PubMed ID: 21484239
[TBL] [Abstract][Full Text] [Related]
26. The NMDA antagonist model for schizophrenia: promise and pitfalls.
Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH
Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841
[TBL] [Abstract][Full Text] [Related]
27. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
Lauterbach EC
Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
[TBL] [Abstract][Full Text] [Related]
28. The Ketamine Antidepressant Story: New Insights.
Alshammari TK
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297563
[TBL] [Abstract][Full Text] [Related]
29. An update on NMDA antagonists in depression.
Pochwat B; Nowak G; Szewczyk B
Expert Rev Neurother; 2019 Nov; 19(11):1055-1067. PubMed ID: 31328587
[No Abstract] [Full Text] [Related]
30. Recent advances in the phencyclidine model of schizophrenia.
Javitt DC; Zukin SR
Am J Psychiatry; 1991 Oct; 148(10):1301-8. PubMed ID: 1654746
[TBL] [Abstract][Full Text] [Related]
31. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
32. NMDA antagonist treatment of depression.
Williams NR; Schatzberg AF
Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
[TBL] [Abstract][Full Text] [Related]
33. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
Large CH
J Psychopharmacol; 2007 May; 21(3):283-301. PubMed ID: 17591656
[TBL] [Abstract][Full Text] [Related]
34. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.
Ficek J; Zygmunt M; Piechota M; Hoinkis D; Rodriguez Parkitna J; Przewlocki R; Korostynski M
BMC Genomics; 2016 May; 17():362. PubMed ID: 27188165
[TBL] [Abstract][Full Text] [Related]
35. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia.
Kapur S; Seeman P
Mol Psychiatry; 2002; 7(8):837-44. PubMed ID: 12232776
[TBL] [Abstract][Full Text] [Related]
36. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
37. Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.
Nagy D; Stoiljkovic M; Menniti FS; Hajós M
Neuropsychopharmacology; 2016 May; 41(6):1486-94. PubMed ID: 26404843
[TBL] [Abstract][Full Text] [Related]
38. N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.
Lin JC; Chan MH; Lee MY; Chen YC; Chen HH
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():7-13. PubMed ID: 27296677
[TBL] [Abstract][Full Text] [Related]
39. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Zanos P; Moaddel R; Morris PJ; Georgiou P; Fischell J; Elmer GI; Alkondon M; Yuan P; Pribut HJ; Singh NS; Dossou KS; Fang Y; Huang XP; Mayo CL; Wainer IW; Albuquerque EX; Thompson SM; Thomas CJ; Zarate CA; Gould TD
Nature; 2016 May; 533(7604):481-6. PubMed ID: 27144355
[TBL] [Abstract][Full Text] [Related]
40. Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates.
Slovik M; Rosin B; Moshel S; Mitelman R; Schechtman E; Eitan R; Raz A; Bergman H
J Neurophysiol; 2017 Aug; 118(2):917-931. PubMed ID: 28468999
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
